{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:27:21Z","timestamp":1793946441500,"version":"4.8.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017594","name":"Science and Technology Program Project in the Health Sector of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijbiomac.2026.154874","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:05:10Z","timestamp":1792227910000},"page":"154874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacological targeting of FKBPL with rapamycin sensitizes triple-negative breast cancer to ferroptosis"],"prefix":"10.1016","volume":"386","author":[{"given":"Rongxue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong'en","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanchu","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.154874_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0010","first-page":"101","article-title":"Prognostic significance and molecular classification of triple negative breast cancer: a systematic review","volume":"21","author":"Dogra","year":"2025","journal-title":"Eur J Breast Health"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0015","first-page":"2261","article-title":"Clinicopathologic features and prognosis of triple negative breast cancer","volume":"89","author":"Zhou","year":"2009","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","article-title":"Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0025","doi-asserted-by":"crossref","DOI":"10.21037\/actr-24-44","article-title":"Utilizing therapeutic response as a criterion for PARP inhibitor maintenance therapy in advanced triple negative breast cancer; promoting personalized medicine","volume":"2","author":"Arthur","year":"2024","journal-title":"AME Clinical Trials Review"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107623","article-title":"FK506 binding proteins and inflammation related signalling pathways; basic biology, current status and future prospects for pharmacological intervention","volume":"215","author":"Annett","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0035","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000123041","article-title":"FKBP family proteins: immunophilins with versatile biological functions","volume":"16","author":"Kang","year":"2008","journal-title":"Neurosignals"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0040","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/eji.1830250239","article-title":"FK506 binding protein 12 mediates sensitivity to both FK506 and rapamycin in murine mast cells","volume":"25","author":"Fruman","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.588913","article-title":"Interactions of FK506 and rapamycin with FK506 binding protein 12 in opportunistic human fungal pathogens","volume":"7","author":"Vellanki","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020395","article-title":"FK506-binding protein like (FKBPL) has an important role in heart failure with preserved ejection fraction pathogenesis with potential diagnostic utility","volume":"13","author":"Chhor","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12885-019-5500-0","article-title":"FKBPL and its peptide derivatives inhibit endocrine therapy resistant cancer stem cells and breast cancer metastasis by downregulating DLL4 and Notch4","volume":"19","author":"McClements","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0060","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12967-025-06118-w","article-title":"The FKBPL-based therapeutic peptide, AD-01, protects the endothelium from hypoxia-induced damage by stabilising hypoxia inducible factor-\u03b1 and inflammation","volume":"23","author":"Ghorbanpour","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0065","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/1078-0432.CCR-10-2241","article-title":"FKBPL and peptide derivatives: novel biological agents that inhibit angiogenesis by a CD44-dependent mechanism","volume":"17","author":"Valentine","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0070","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/ATVBAHA.114.304539","article-title":"FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis","volume":"35","author":"Yakkundi","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0080","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trsl.2026.06.010","article-title":"The HDAC inhibitor RM-3-22 suppresses triple-negative breast Cancer by uncoupling autophagy to drive FSP1-dependent Ferroptosis","volume":"295","author":"Chatterjee","year":"2026","journal-title":"Transl. Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111760","article-title":"Apatinib combined with paclitaxel suppresses synergistically TNBC progression through enhancing ferroptosis susceptibility regulated SLC7A11\/GPX4\/ACSL4 axis","volume":"131","author":"Ma","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.597434","article-title":"Role of GPX4-mediated Ferroptosis in the sensitivity of triple negative breast Cancer cells to Gefitinib","volume":"10","author":"Song","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0100","first-page":"649","article-title":"Targeting the 4EBP1\/HSP90\u03b2\/Nrf2 axis sensitizes \u03b2-catenin-mutant hepatocellular carcinoma to mTOR inhibitors via ferroptosis induction","volume":"14","author":"Li","year":"2026","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2026.154874_bb2100","doi-asserted-by":"crossref","first-page":"118433","DOI":"10.1016\/j.bcp.2026.118433","article-title":"Dual GPX4\/PARP inhibitor YHD-26 exerts potent antitumor activity against triple-negative breast cancer via ferroptosis and DNA damage synergy","volume":"254","author":"Bao","year":"2026","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0105","article-title":"Fluorinated prodrug-engineered nano-remodeler relieves tumor hypoxia for dual-enhanced ferroptosis-immunotherapy","volume":"6","author":"Lei","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0110","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0115","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","article-title":"Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer","volume":"21","author":"Burstein","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.578345","article-title":"Integration of online omics-data resources for Cancer research","volume":"11","author":"Das","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0125","doi-asserted-by":"crossref","first-page":"D509","DOI":"10.1093\/nar\/gkab1060","article-title":"FuzDB: a new phase in understanding fuzzy interactions","volume":"50","author":"Hatos","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0130","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10549-011-1457-7","article-title":"Bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer","volume":"131","author":"J\u00e9z\u00e9quel","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0135","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0140","doi-asserted-by":"crossref","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","article-title":"TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment","volume":"51","author":"Han","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0145","article-title":"GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels","volume":"24","author":"Liu","year":"2023","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0150","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","article-title":"TCGAplot: an R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data","volume":"24","author":"Liao","year":"2023","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0155","first-page":"28","article-title":"GNINA 1.3: the next increment in molecular docking with deep learning","volume":"17","author":"McNutt","year":"2025","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5090","article-title":"Exploring protein functions from structural flexibility using CABS-flex modeling","volume":"33","author":"Nithin","year":"2024","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0165","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","article-title":"A single-cell and spatially resolved atlas of human breast cancers","volume":"53","author":"Wu","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0170","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","volume":"20","author":"Jin","year":"2025","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0180","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat. Appl. Genet. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0185","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-9-559","article-title":"WGCNA: an R package for weighted correlation network analysis","volume":"9","author":"Langfelder","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0190","article-title":"clusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0195","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","article-title":"Ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2","volume":"38","author":"Gustavsson","year":"2022","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0200","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/nsr\/nwaa023","article-title":"MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3","volume":"7","author":"Li","year":"2020","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216732","article-title":"Acidosis activates breast cancer ferroptosis through ZFAND5\/SLC3A2 signaling axis and elicits M1 macrophage polarization","volume":"587","author":"Xiong","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0210","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.drudis.2012.01.002","article-title":"The therapeutic and diagnostic potential of FKBPL; a novel anticancer protein","volume":"17","author":"Robson","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055075","article-title":"The anti-migratory effects of FKBPL and its peptide derivative, AD-01: regulation of CD44 and the cytoskeletal pathway","volume":"8","author":"Yakkundi","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ijbiomac.2026.154874_bb0220","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202519368","article-title":"GSH as an A-A type allosteric activator of PKM2: modulating cancer cell homeostasis and ferroptosis susceptibility","volume":"13","author":"Chen","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0225","article-title":"Ferrocene conjugated glutathione consumption for enhanced ferroptosis therapy and chemotherapy","volume":"18","author":"Zhang","year":"2025","journal-title":"Nano Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26209902","article-title":"Targeting Ferroptosis as the Achilles\u2019 heel of breast Cancer: mechanisms and therapeutic opportunities from a comprehensive systematic review","volume":"26","author":"Szulc","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0235","first-page":"881","article-title":"Kelch-like ech-associated protein 1\/nuclear factor E2-related factor 2\/antioxidant response element pathway alleviates ferroptosis in sepsis by regulating oxidative stress","volume":"33","author":"Li","year":"2021","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108444","article-title":"Concurrent mutations in STK11 and KEAP1 promote Ferroptosis protection and SCD1 dependence in lung Cancer","volume":"33","author":"Wohlhieter","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115733","article-title":"The role of FK506-binding protein 12 in cancer: from biology to clinical application","volume":"167","author":"Ye","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41417-020-0182-y","article-title":"Interplay between MTOR and GPX4 signaling modulates autophagy-dependent ferroptotic cancer cell death","volume":"28","author":"Liu","year":"2021","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0255","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","article-title":"mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.redox.2017.08.015","article-title":"Iron accumulation in senescent cells is coupled with impaired ferritinophagy and inhibition of ferroptosis","volume":"14","author":"Masaldan","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0265","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41419-022-05384-6","article-title":"Ferroptosis: a double-edged sword mediating immune tolerance of cancer","volume":"13","author":"Dang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0270","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1074\/jbc.M807698200","article-title":"CD96 interaction with CD155 via its first Ig-like domain is modulated by alternative splicing or mutations in distal Ig-like domains","volume":"284","author":"Meyer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0275","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1084\/jem.20031885","article-title":"Activation of natural killer cells and dendritic cells upon recognition of a novel CD99-like ligand by paired immunoglobulin-like type 2 receptor","volume":"199","author":"Shiratori","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0280","article-title":"The mechanism underlying metastasis in triple-negative breast cancer: focusing on the interplay between ferroptosis, epithelial-mesenchymal transition, and non-coding RNAs","volume":"15","author":"Chen","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba8968","article-title":"Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis","volume":"6","author":"Verma","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0290","first-page":"2079","article-title":"Triple-negative breast cancer and ferroptosis: expression profiling of key regulatory genes","volume":"21","author":"Antmen","year":"2025","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0295","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41416-019-0649-5","article-title":"FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer","volume":"122","author":"Annett","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0300","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-13-0595","article-title":"Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway","volume":"19","author":"McClements","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0305","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2010.3211","article-title":"Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases","volume":"13","author":"Villeneuve","year":"2010","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0310","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12935-022-02706-8","article-title":"Recent advances and limitations of mTOR inhibitors in the treatment of cancer","volume":"22","author":"Ali","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0315","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s11684-020-0812-7","article-title":"mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?","volume":"15","author":"Sun","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.ijbiomac.2026.154874_bb0320","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1073\/pnas.2017152117","article-title":"Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis","volume":"117","author":"Yi","year":"2020","journal-title":"Proc. Natl. Acad. Sci."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026048269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026048269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:34:06Z","timestamp":1793943246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026048269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":65,"alternative-id":["S0141813026048269"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154874","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological targeting of FKBPL with rapamycin sensitizes triple-negative breast cancer to ferroptosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.154874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"154874"}}